Warning Letter Roundup: Four Companies Hit for GMP Violations By Sam | May 6, 2019 The FDA issued warning letters to four drugmakers for various GMP violations at their facilities, including quality unit shortcomings. Source: Drug GMP Report Posted in Drug GMP Report